Analystreport

Correvio Pharma Corp (NASDAQ: CORV) was given a new $7.00 price target on by analysts at Canaccord Genuity. They now have a "buy" rating on the stock.

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report